PB 76 of 2020 National Health (subsection 99ACB(1) taken not to have applied) Determination 2020 I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make the following determination. Dated 30 July 2020 NIKOLAI TSYGANOV Acting Assistant Secretary Pricing and PBS Policy Branch Technology Assessment and Access Division Department of Health Contents 1 Name 2 Commencement 3 Authority 4 Definitions 5 Subsection 99ACB(1) is taken not to have applied 1 Name This instrument is the National Health (subsection 99ACB(1) taken not to have applied) Determination 2020. This instrument may also be cited as PB 76 of 2020. 2 Commencement (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms. Commencement information Column 1 Column 2 Column 3 Provisions Commencement Date/Details 1. The whole of this instrument 1 August 2020. Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument. (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument. 3 Authority This instrument is made under section 99AEI of the National Health Act 1953. 4 Definitions In this instrument: Act means the National Health Act 1953. 5 Subsection 99ACB(1) is taken not to have applied (1) For the purposes of subsection 99ACB(3) of the Act, subsection 99ACB(1) of the Act is taken not to have applied to the MERCAPTOPURINE-LINK brand of mercaptopurine, tablet containing mercaptopurine monohydrate 50 mg, oral.